Area of focus

IP Licensing, Commercialization, and Technology Transfer

IP can be exploited, commercialized, or transferred in many ways. We understand them all. IP rights must be secured to protect against infringements and attacks. Licensing agreements have to...

Representative experience

Advising large Japanese pharma company on its bid for a licence for a cancer drug from a UK biotechnology company involving a review of the patent situation in 19 jurisdictions.

Advising a public sector organization on the establishment of a US$800m SAP-based business transformation framework agreement.

Advising a manufacturer of construction equipment on IP licenses and technical services agreements in joint ventures with Chinese and Japanese entities.

Advising Genzyme on its strategic agreement with Bayer regarding Genzyme's hematologic oncology portfolio, including worldwide rights for Alemtuzumab (earn-out arrangement).

Wearable technology - IP opportunities and risks

Join us on 16 or 21 August for the fourth in our LimeGreen Live webinar series, in conjunction with the Hogan Lovells Consumer Industry Sector Group. 

Quick view Full view

Blog Post

New Luxembourg IP Regime 2018

Have you created, developed or improved inventions or copyrighted software since 31 December 2007 through research and development activities?

Quick view Full view

Hogan Lovells Publications

Brexit Effect Note: the legal Implications behind the headlines

A comprehensive guide providing insight for businesses on the impact of a British exit from the EU. The impact for businesses will vary depending on the sector and markets businesses...

Quick view Full view
Loading data